CARB-X Executive Director Kevin Outterson joined the Canadian House of Commons Standing Committee on Science and Research to testify on the #AMR crisis, highlighting the urgent need for both push and pull incentives to support AMR R&D. 🔗 Watch here: bit.ly/4omqE57#AMR

Join CARB-X Senior Alliance Manager Su Chiang, PhD, at the 2nd Annual Antimicrobial Resistance and Infectious Diseases Symposium for her presentation “CARB-X: Stimulating and supporting innovation against AMR.” 📅 Nov. 13 ⏰ 9:20 – 9:40 AM ET 🔗 Register here: bit.ly/43z350A

CARB-X Chief of External Affairs Damiano de Felice, PhD, and other World Economic Forum “What Is the Cost of Underinvesting in Health?” panelists discussed why health should be seen as an investment rather than a cost. #AMGFCC25 #MedSky 🧪 🔗 Watch here: bit.ly/3WKnBrv#AMGFCC25

At a recent World Health Summit panel, CARB-X Executive Director Kevin Outterson discussed improving data collection and usage for impactful and accountable AMR policy implementation, including the potential of AI and real-time hospital data. 🧪 #IDSky #WHS2025 🔗 bit.ly/3JauCyw#IDSky

CARB-X today announced that Richard Alm, Ph.D., will be appointed as Interim Chief of Research & Development (R&D). 🔗 Read here:

Attending @bactivac.bsky.social Birmingham? Join CARB-X Alliance Director Ed Buurman, PhD, for his presentation “Supporting AMR Vaccine R&D.” #BactiVacEvents #IDSky 📅 Wednesday, November 5 ⏰ 11:15 – 11:45 AM GMT

CARB-X Executive Director and Boston University School of Law professor Kevin Outterson spoke with The Brink about the latest Global Antibiotic Resistance Surveillance (GLASS) report released by WHO. #IDSky 🧪 🔗 Read here: bit.ly/3WoIUhZ#IDSky

A new article in Science Magazine highlights newly published research and the growing debate about prophylactic use of azithromycin in Africa, which has the potential to save vulnerable children’s lives, but could accelerate antibiotic resistance. #IDSky #MedSky 🧪 🔗 Read here: bit.ly/4hog4I3#IDSky

Join CARB-X Director of External Affairs Will Hall at Infection 2025 – @bsacandjac.bsky.social Winter Conference for his presentation “Is anything working? PPP, push pull and nonprofit funding incentives.” #AMGFCC25 📅 Oct. 27 ⏰ 9:55 – 10:15 AM GMT 🔗 Register here: bit.ly/4nWRQr7#AMGFCC25

Today is #WorldPhageDay, recognizing the potential of bacteriophages to address #AMR. Phages could offer targeted alternatives or complement traditional antibiotics. CARB-X supports phage-based innovation including projects from Locus Biosciences, SNIPR BIOME#WorldPhageDay#AMRand PHIOGEN. #IDSky 🧪

Join CARB-X Chief Scientific Officer Richard Alm, PhD, at the @latrobeuni.bsky.social Frontiers in Infectious Diseases Innovation event for his presentation “CARB-X – Accelerating the Development of Novel Products to Tackle AMR.” #IDSky 🧪 📆 October 29 ⏰ 5 – 7 PM AEDT 🔗 Register: bit.ly/3IOo9Jy

Congratulations @lumenbio.bsky.social! CARB-X is proud to have supported LMN-0403, an orally delivered preventative and treatment of diarrheal diseases caused by C. jejuni and enterotoxigenic E. coli, since August 2020.

A Communications Medicine publication proposes a comprehensive One Health stewardship framework to address AMR. CARB-X and Global Antibiotic R&D Partnership (GARDP) are recognized as important push incentives supporting antibiotic R&D. #IDSky 🧪 🔗 Read here: bit.ly/3KSyMvh#IDSky

Join CARB-X Chief of External Affairs Damiano de Felice at the World Economic Forum Annual Meeting of the Global Future Councils panel “What Is the Cost of Underinvesting in Health?” #AMGFCC25 📆 Wednesday, October 15 ⏰ 12:15 – 1 PM GST 🔗 Watch the livestream here: bit.ly/3LaW1AP#AMGFCC25

Join CARB-X Alliance Director Ed Buurman, PhD at the World Vaccine Congress Europe keynote panel “Vaccines & AMR – Turning Commitment into Practical Action.” 🧪 #IDSky #WVCEU 📆 Tuesday, October 14 ⏰ 5 PM CEST 🔗 Register now: bit.ly/3IdV8Xm#IDSky

Join CARB-X Executive Director @koutterson.bsky.social at the @worldhealthsummit.bsky.social panel “Leveraging Evidence and Tools to Advance AMR Policy Implementation.” 🧪 #IDSky #WHS2025 📆 Sunday, October 12 ⏰ 11 – 12:30 CEST 🔗 Register now: bit.ly/4maIw0R#IDSky

Thank you to 130+ attendees who convened at @imperialcollege for the 2025 CARB-X PD Conference! Clinicians, CARB-X graduates, and CARB-X R&D leaders shared innovations in therapeutics, preventatives, & diagnostics to address antibiotic resistance.

That's a wrap on #GAMRIC2025! See today's highlights over on LinkedIn - t.ly/nr1sV Thanks to all who attended and we look forward to seeing you again next year for #GAMRIC2026. @carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

That’s a wrap on the first-ever #GAMRIC2025! Thanks to all who joined us in London to tackle AMR innovation challenges head-on—from STIs and TB to neonates and diagnostics. Let’s keep building the future of #AMR R&D—see you at #GAMRIC2026! #CARBX #GlobalHealth

Join CARB-X Alliance Director Betsy Wonderly Trainor at The MedTech Conference panel “The Point of Impact: Charting the Future of Decentralized Diagnostics.” 🧪 #IDSky #MTC25 📆 Monday, October 6 ⏰ 9:30 – 10:30 AM PT 🔗 Register now: bit.ly/3IdS6Cs#IDSky

Day 2 at #GAMRIC2025 in London! Today’s sessions cover: 🫁 The urgent need for new tools to treat LRTIs 🦠 TB drug discovery 🔬 The vital role of diagnostics in fighting #AMR 💡 And more! CARB-X is proud to be part of these critical conversations. #CARBX #GlobalHealth

The inaugural Global AMR Innovators Conference (GAMRIC) has begun! Stay tuned for updates and join the conversation here or on Bluesky using #GAMRIC2025. @carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

Day 1 at #GAMRIC2025 in London! Today’s sessions highlight: 🌍 The global AMR crisis 🧫 Developing therapeutics for neonatal infections ⚖️ AMR policy 💡 And more! Proud to join researchers and funders working to address this urgent global public health challenge.

Countdown to #GAMRIC2025: The inaugural Global AMR Innovators Conference kicks off tomorrow in London! Join CARB-X and global leaders as we dive into discussions about #AMR policy and antimicrobial research and development. #GlobalHealth #CARBX #IDSky 🧪

At the @eupohamr.bsky.social kickoff, CARB-X Director of External Affairs Louise Norton-Smith spoke on a panel about the importance of seeking new opportunities with partners outside the traditional AMR ecosystem to bring fresh perspectives, bridge knowledge gaps, and broaden impact.

Register now for the 2025 BARDA Innovation Symposium! BARDA-supported innovators, other U.S. government partners, investors, and strategic partners will gather to showcase innovative technologies and network. 🧪 #IDSky 📆 Nov. 20, 2025 🔗 Register here:

💼 CARB-X is hiring a CFO! We are looking for someone with at least eight years of experience in a senior finance role who has previously worked for nonprofits. This position is part of the CARB-X Executive Team. ➡️ Apply today! bit.ly/3YLyo5V

Today marks the official launch of the @eupohamr.bsky.social in Brussels! CARB-X is proud to join this global partnership of over 50 organizations from 30 countries, united in a shared mission: to address the growing threat of #AMR through a truly integrated One Health approach.

Sept. 13 is #WorldSepsisDay. In 2025, several projects which aim to address bacterial infections that can lead to sepsis entered the CARB-X portfolio, including Melio, Immunartes, AstraDx, Immunethep, Baxiva, PHIOGEN, and QuantaMatrix. #IDSky 🧪 🔗 Learn more: bit.ly/4pmhiaC#WorldSepsisDay.

🗞️ New interview! CARB-X Alliance Director Betsy Wonderly Trainor and QuantaMatrix Founder and CEO Sunghoon Kwon spoke with GenomeWeb about CARB-X’s recent award to QuantaMatrix and the need for rapid diagnostics for sepsis diagnoses. #IDSky 🧪 🔗 Read here:

📘 New publication! CARB-X Alliance Director Vega Masignani co-authored a @natureportfolio.nature.com Vaccines paper outlining early de-risking strategies for vaccine development to help accelerate vaccine R&D while reducing the likelihood of costly late-stage failures. 🧪 🔗 bit.ly/4meyxIV

CARB-X has awarded Zeteo Tech US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections. 🧪 #IDSky 🔗 Read here: bit.ly/3HAYZgS

📘 New publication supported by CARB-X! “Infection risk associated with colonization by multidrug-resistant Gram-negative bacteria: An umbrella review and meta-analysis.” 🧪 #IDSky 🔗 Read here: bit.ly/3V4tWNi#IDSky

CARB-X has awarded QuantaMatrix US$2.85M to execute a workplan to develop its rapid diagnostic platform to detect sepsis, especially in vulnerable neonates. 🧪 #IDSky 🔗 Read here: bit.ly/45OlTsV

Attending Queenstown Research Week? Join CARB-X Chief Scientific Officer Richard Alm, PhD, for his presentation “CARB-X – Accelerating the Development of Novel Products to Tackle AMR.” 📆 Wednesday, September 3 ⏰ 3:30 PM NZST

CARB-X has awarded PHIOGEN US$1.1M to evaluate PHI-BI-01, its novel, dual-action therapeutic designed to treat and prevent ExPEC bloodstream infections, particularly those caused by multidrug-resistant strains. 🧪 #IDSky 🔗 Read here: bit.ly/41eNClc

📢 GAMRIC is SOLD OUT! 500+ abstract submissions were received, and 20 travel grants were awarded to Early Career Researchers and LMIC residents. We look forward to expanding our capacity for next year’s event and welcoming even more participants to GAMRIC in the years to come!

CARB-X has awarded Baxiva US$3M to develop its multivalent glycoconjugate vaccine to prevent extraintestinal pathogenic Escherichia coli (ExPEC) infections. #IDSky 🧪 🔗 Read here: bit.ly/3Hzo5fU#IDSky

🗞️ New interview! @camcdevitt.bsky.social and @ellacasale.bsky.social of @thedohertyinst.bsky.social spoke to The Australian Financial Review about developing PBT2, a CARB-X-supported oral therapeutic that aims to restore the activity of antibiotics used to treat CABP. 🧪 #IDSky 🔗 bit.ly/45j832Q

Join CARB-X Chief of External Affairs @damidefelice.bsky.social for the Global Health Security Agenda AMR Action Package webinar “Promoting Diagnostics and Antimicrobial Equity for AMR Control.” 🧪 #IDSky 📆 Wednesday, August 20 ⏰ 8 – 9 AM ET 🔗 Join the webinar here: bit.ly/41OOE7A

AI is opening remarkable new doors in antibiotic discovery — including two promising compounds that could one day treat drug-resistant gonorrhea and MRSA. 🧪 #IDSky 🔗 Read more about this exciting step forward from MIT’s research team:

Read below to learn about Italy's recent commitment to its national pull incentive, solidifying its legal & procedural foundation. CARB-X is pleased to see its newest funding partner taking additional steps to support AMR innovation. @damidefelice.bsky.social @johnhrexmd.bsky.social bit.ly/41lTau8

💼 CARB-X is hiring! Are you a collaborative, self-starter with Salesforce Administrator experience? We are hiring a SALESFORCE ADMINISTRATOR & BUSINESS ANALYST who will collaborate with internal CARB-X teams and external constituents. ➡️ Apply now! bit.ly/3YLyo5V

[email protected] highlights progress made to address AMR in the nine years since the O’Neill Review was published, including CARB-X’s global efforts to accelerate early-stage antibacterial innovation and fill the gap left by big pharma. 🧪 #IDSky 🔗 Read here: bit.ly/4kVTFlT

@cgdev.orglaunched an interactive tool that models the burden of AMR country by country as its report estimates AMR will cause millions more deaths worldwide and cost the global economy nearly $2 trillion per year by 2050. 🧪 #IDSky 🔗 Read here: bit.ly/452ndrO#IDSky

CARB-X Executive Director @koutterson.bsky.social joined a working group convened by @cgdev.org and @uchi-msa.bsky.social that aims to develop an advance market commitment for a rapid diagnostic test for neonatal sepsis in LMICs. 🧪 #IDSky 🔗 Read here: bit.ly/44ku4xJ#IDSky

CARB-X is proud to join the Australian Antimicrobial Resistance Network, Australia’s leading AMR network. Addressing AMR requires global collaboration, and CARB-X is committed to accelerating innovation through international partnerships. 🔗 Learn more about AAMRNet: bit.ly/44ztMlt

Surveillance of antimicrobial use and resistance ‘in isolation is like counting raindrops in a thunderstorm’ - we need more investment in innovation and prevention of AMR. Dr Richard Alm Speaking in Adelaide #MTPConnect #AAMRNet #AMR #PublicHealth #antimicrobials @carb-x.bsky.social

Join CARB-X Chief Scientific Officer Richard Alm, PhD at his @aussocmic.bsky.social presentation highlighting some CARB-X portfolio graduates with key learnings around effective translation of novel assets into clinical development. 🧪 📆 July 16 ⏰ 9 – 10:30 AM ACST 🔗 bit.ly/44L61bq

Join CARB-X Chief Scientific Officer Richard Alm, PhD at a MTPConnect panel discussing innovation and commercialization in antibiotic R&D, sharing insights on translating AMR research into real-world solutions. 🧪 📆 Monday, July 14 ⏰ 12 – 2 PM ACST 🔗 Register now: bit.ly/4kWKp1x